CervoMed Inc.

CRVO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$7,727-$6,258-$4,894-$6,706
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$361$338
Change in WC$1,463-$519$890-$1,300
Other Non-Cash-$201$262-$252-$383
Operating Cash Flow-$6,465-$6,515-$3,894-$8,051
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$9,755-$7,103-$3,633
Inv. Sales/Matur.$0$9,500$12,500$12,940
Other Inv. Act.$7,582$0$0$0
Investing Cash Flow$7,582-$255$5,397$9,307
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$4,589$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$4,589$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$1,117-$2,181$1,502$1,256
Supplemental Information
Beg. Cash$8,321$10,502$8,999$7,744
End Cash$9,437$8,321$10,502$8,999
Free Cash Flow-$6,465-$6,515-$3,894-$8,051
CervoMed Inc. (CRVO) Financial Statements & Key Stats | AlphaPilot